GAP43 and Alzheimer disease: Previous independent studies have reported associations between CSF GAP-43 and global cognitive decline (Lu, 2022; Öhrfelt et al., 2022; Qiang et al., 2022; Sandelius et al., 2019) and episodic memory impairment (Lee et al., 2025) among cognitively normal, MCI, and AD samples.